HUP0103711A3 - Novel antimicrobial compounds - Google Patents

Novel antimicrobial compounds

Info

Publication number
HUP0103711A3
HUP0103711A3 HU0103711A HUP0103711A HUP0103711A3 HU P0103711 A3 HUP0103711 A3 HU P0103711A3 HU 0103711 A HU0103711 A HU 0103711A HU P0103711 A HUP0103711 A HU P0103711A HU P0103711 A3 HUP0103711 A3 HU P0103711A3
Authority
HU
Hungary
Prior art keywords
antimicrobial compounds
novel antimicrobial
novel
compounds
antimicrobial
Prior art date
Application number
HU0103711A
Other languages
English (en)
Original Assignee
Sankyo Company Ltd Chuo Ku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Company Ltd Chuo Ku filed Critical Sankyo Company Ltd Chuo Ku
Publication of HUP0103711A2 publication Critical patent/HUP0103711A2/hu
Publication of HUP0103711A3 publication Critical patent/HUP0103711A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/167Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • C12P19/40Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
HU0103711A 1998-07-09 1999-07-09 Novel antimicrobial compounds HUP0103711A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19428598 1998-07-09
JP26944598 1998-09-24
PCT/JP1999/003718 WO2000002892A1 (en) 1998-07-09 1999-07-09 Novel antibacterial compounds

Publications (2)

Publication Number Publication Date
HUP0103711A2 HUP0103711A2 (hu) 2002-02-28
HUP0103711A3 true HUP0103711A3 (en) 2003-11-28

Family

ID=26508414

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103711A HUP0103711A3 (en) 1998-07-09 1999-07-09 Novel antimicrobial compounds

Country Status (23)

Country Link
US (2) US6472384B1 (hu)
EP (3) EP1095947B1 (hu)
KR (2) KR100622889B1 (hu)
CN (1) CN1181087C (hu)
AT (2) ATE356825T1 (hu)
AU (1) AU751470B2 (hu)
BR (1) BR9911965A (hu)
CA (1) CA2337225C (hu)
DE (2) DE69935513T2 (hu)
DK (2) DK1319666T3 (hu)
ES (2) ES2284260T3 (hu)
HK (2) HK1053127B (hu)
HU (1) HUP0103711A3 (hu)
ID (1) ID27955A (hu)
IL (3) IL140731A0 (hu)
NO (1) NO322083B1 (hu)
NZ (1) NZ509233A (hu)
PL (1) PL200426B1 (hu)
PT (1) PT1095947E (hu)
RU (1) RU2209210C2 (hu)
TR (1) TR200100059T2 (hu)
WO (1) WO2000002892A1 (hu)
ZA (1) ZA200100200B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI245047B (en) 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
EP1322504A1 (de) 2000-09-25 2003-07-02 Volkswagen AG Airbagvorrichtung und betriebsverfahren dafür
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
WO2005034857A2 (en) * 2003-09-05 2005-04-21 Sequella, Inc. Methods and compositions comprising diamines as new anti-tubercular therapeutics
WO2006025920A2 (en) * 2004-06-19 2006-03-09 Human Biomolecular Research Institute Modulators of central nervous system neurotransmitters
US20090068325A1 (en) * 2007-09-10 2009-03-12 Gil Depicciotto Method of treatment of fresh produce
US20090281054A1 (en) * 2008-05-06 2009-11-12 Venkata Reddy Compositions and methods comprising capuramycin analogues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60259190A (ja) * 1984-06-06 1985-12-21 Kanto Ishi Pharma Co Ltd 新抗生物質カプラマイシン及びその製造法
US5034381A (en) 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH05148293A (ja) * 1991-11-28 1993-06-15 Mect Corp 新規カプラマイシン誘導体およびその製造方法
GB9307043D0 (en) 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
TWI245047B (en) 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives

Also Published As

Publication number Publication date
CA2337225C (en) 2009-05-26
EP1319666B1 (en) 2005-09-14
ID27955A (id) 2001-05-03
NZ509233A (en) 2003-05-30
TR200100059T2 (tr) 2001-05-21
ATE304548T1 (de) 2005-09-15
IL140731A0 (en) 2002-02-10
KR100729196B1 (ko) 2007-06-19
BR9911965A (pt) 2001-05-29
CN1181087C (zh) 2004-12-22
DK1319666T3 (da) 2005-12-05
IL140731A (en) 2008-06-05
US20030069204A1 (en) 2003-04-10
DE69927306T2 (de) 2006-07-06
PT1095947E (pt) 2007-06-20
ZA200100200B (en) 2002-06-26
PL345403A1 (en) 2001-12-17
WO2000002892A1 (en) 2000-01-20
DE69935513D1 (de) 2007-04-26
CN1317008A (zh) 2001-10-10
KR20010083101A (ko) 2001-08-31
US6844173B2 (en) 2005-01-18
PL200426B1 (pl) 2009-01-30
HK1053127A1 (en) 2003-10-10
EP1095947B1 (en) 2007-03-14
NO20010105L (no) 2001-03-08
HK1053063A1 (zh) 2003-10-10
ES2248654T3 (es) 2006-03-16
HUP0103711A2 (hu) 2002-02-28
RU2209210C2 (ru) 2003-07-27
KR20060011919A (ko) 2006-02-03
EP1095947A4 (en) 2002-01-16
NO20010105D0 (no) 2001-01-08
KR100622889B1 (ko) 2006-09-12
DE69935513T2 (de) 2007-11-29
EP1095947A1 (en) 2001-05-02
NO322083B1 (no) 2006-08-14
IL187551A (en) 2009-12-24
ES2284260T3 (es) 2007-11-01
IL187551A0 (en) 2008-03-20
AU751470B2 (en) 2002-08-15
US6472384B1 (en) 2002-10-29
DK1095947T3 (da) 2007-07-16
EP1319406A1 (en) 2003-06-18
CA2337225A1 (en) 2000-01-20
EP1319666A1 (en) 2003-06-18
AU4650599A (en) 2000-02-01
DE69927306D1 (de) 2005-10-20
HK1053127B (zh) 2005-12-30
ATE356825T1 (de) 2007-04-15

Similar Documents

Publication Publication Date Title
SG70667A1 (en) Antimicrobial composition
GB9801392D0 (en) Novel compounds
HUP0103711A3 (en) Novel antimicrobial compounds
IL137444A0 (en) Antimicrobial compounds
HK1034262A1 (en) Novel antibacterial compounds
AU2002318791A1 (en) Antimicrobial compounds
GB9800289D0 (en) Novel compounds
GB9800317D0 (en) Novel compounds
GB9800324D0 (en) Novel compounds
GB9800337D0 (en) Novel compounds
GB9801630D0 (en) Novel compounds
GB9801632D0 (en) Novel compounds
GB9801633D0 (en) Novel compounds
GB9801634D0 (en) Novel compounds
GB9801635D0 (en) Novel compounds
GB9801643D0 (en) Novel compounds
GB9801882D0 (en) Novel compounds
GB9802387D0 (en) Novel compounds
GB9802638D0 (en) Novel compounds
GB9802639D0 (en) Novel compounds
GB9802640D0 (en) Novel compounds
GB9802644D0 (en) Novel compounds
GB9802645D0 (en) Novel compounds
GB9802646D0 (en) Novel compounds
GB9802653D0 (en) Novel compounds

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: SEQUELLA, INC., US

Free format text: FORMER OWNER(S): SANKYO COMPANY, LIMITED, JP

FD9A Lapse of provisional protection due to non-payment of fees